Profilo
Robert Dwyer Nolan is the founder of Cardiff Biologicals Ltd. He is currently a Non-Executive Director at Phico Therapeutics Ltd. He was previously the Chairman of Cardiff Protides Ltd. and held various Director positions at AstraZeneca PLC, Genedrive Plc, Epistem Ltd., NeuTec Pharma Ltd., and F2G Ltd. He earned a doctorate degree from King's College London.
Precedenti posizioni note di Robert Dwyer Nolan
| Società | Posizione | Fine |
|---|---|---|
| GENEDRIVE PLC | Direttore/Membro del Consiglio | 31/12/2018 |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Provides biotechnology research services | Direttore/Membro del Consiglio | 01/10/2008 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2004 |
Cardiff Biologicals Ltd.
Cardiff Biologicals Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development service in health sector | Fondatore | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Direttore/Membro del Consiglio | - |
Formazione di Robert Dwyer Nolan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Genedrive Plc
Genedrive Plc Medical SpecialtiesHealth Technology Manufactures and markets molecular diagnostics testing equipment | Health Technology |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Protides Ltd.
Cardiff Protides Ltd. Miscellaneous Commercial ServicesCommercial Services Operates drug design, synthesis and evaluation of leukemia and tumors | Commercial Services |
Cardiff Biologicals Ltd.
Cardiff Biologicals Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development service in health sector | Commercial Services |
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. BiotechnologyHealth Technology Develops novel platform technology designed to overcome antibacterial resistance | Health Technology |
















